Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30
Published October 16, 2019 · Recall initiated: September 6, 2019
Summary
FDA records drug Class III recall D-0131-2020, published October 16, 2019 and initiated September 6, 2019. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 5,849 bottles; Lot: Lot # 1344864A, exp. date 10/2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
GMP Deviation: lot not intended for commercial distribution.
What to do
Voluntary: Firm initiated · Letter
Get an email if MATZIM LA has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MATZIM LA
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.
- Lot
- Lot # 1344864A, exp. date 10/2020
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, ManufacturedAugust 10, 2022
- FDAPrednisolone Sodium Phosphate Oral Solution, 15 mg/5 mL, packaged in a 8 fl oz (237 mL) bottle, Rx only,October 16, 2019
- FDADrKids Himasal Natural Nasal Saline Solution, packaged in Pre-measured Singe-Use Vials a) 0.5 mL Each (20October 16, 2019
- FDASandoz Ranitidine Hydrochloride Capsules 150mg 500 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJOctober 16, 2019
- FDAEstradiol tablets, 0.5 mg, 100-count bottles, Rx only, Distributed by Epic Pharma, LLC Laurelton, NY 11413,October 16, 2019
- FDASandoz Ranitidine Hydrochloride Capsules 150mg 60 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJOctober 16, 2019
Questions about this recall
Was Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30 recalled?
Yes. FDA published recall D-0131-2020 on October 16, 2019. Reported hazard: GMP Deviation: lot not intended for commercial distribution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MATZIM LA.